Have you ever had an MRI scan? Sometimes the doctor says, 'We need to give you a contrast dye to get a clear picture of the inside of your body,' right? Most of the time, this is very safe. But today we're talking about a very, very rare problem, especially for someone with kidney disease. Don't be afraid of this, because it's so rare that you don't see it anymore. But it's important to know.
Simply put, what is Nephrogenic Systemic Fibrosis (NSF)?
Nephrogenic Systemic Fibrosis (NSF) is a very rare condition. It most often occurs in people with kidney disease after they are given a type of contrast dye called `gadolinium-based contrast agents (GBCAs). Gadolinium is a chemical in this dye. Doctors use this contrast dye to get clearer images during scans like Magnetic Resonance Imaging (MRI).
If you have kidney damage, your kidneys have difficulty filtering these GBCAs from your blood, which is why you are at risk for NSF.
This disease can cause your skin to thicken, tighten, swell, and itch . Sometimes, a condition called `joint contracture` can occur. This means that your muscles and tendons become locked in one position (bent or extended). NSF can also affect internal organs like your heart and lungs. This is because the tissues and muscles in your chest can become stiff. There is currently no cure to stop the progression of this disease or reverse its effects.
But remember this: Now that everyone knows about this risk, they have stopped giving dangerous contrast dyes to people with kidney disease. That's why this disease is almost unheard of now.
How common is this disease really?
This is an incredibly rare disease. In fact, no new cases of this disease have been reported for over 10 years. After 2006, when the medical community became aware of the link between GBCAs and kidney disease, the number of cases of this disease decreased dramatically. So, this shows that there is no need to be afraid of this anymore.
What are the symptoms of NSF?
Symptoms can appear the same day the contrast dye is given or several months later. Symptoms usually appear within a few weeks.
Let's take a look at the main symptoms.
| Symptom category | Explanation |
|---|---|
| Skin changes | Your skin becomes swollen, tight, and thickened. This most often occurs on the arms, legs, and torso. The face is rarely affected. |
| Skin appearance | Dark spots or bumps on the skin. Over time, the skin may take on a dimpled appearance, similar to an orange peel. |
| Skin sensation | Itchy, burning, or painful skin. |
| Difficulty moving | As the skin thickens and swells, muscles and joints cannot move normally. |
| Internal influences | Severe muscle weakness. Muscle stiffness causes the limb to become unable to bend or straighten properly (Loss of range of motion). |
As fibrosis progresses, it can cause scar tissue to form in the muscles, lungs, esophagus, eyes, and heart. This can impair the function of these organs. It can lead to long-term and permanent disability, and in some people, it can be fatal.
Why does this NSF situation occur?
Most cases of NSF have been reported after exposure to gadolinium-based contrast agents (GBCAs). It is still unclear exactly how the chemical gadolinium causes NSF. However, there is a clear link between kidney disease and GBCAs. Also, the risk appears to be higher if you are given high doses of gadolinium or if you use certain (older) GBCAs.
This condition occurs most often in people with chronic kidney disease (CKD) or those on dialysis.
But I say again, don't be afraid. There hasn't been a new case of this in almost 15 years. The reason is that doctors are now very aware of this risk. That's why they don't give old, risky GBCAs to people with kidney disease. They now use much safer, newer contrast agents.
What are the treatments for NSF?
There is currently no specific treatment approved for NSF. Because the disease is so rare, research into treatment is limited. However, there are several treatments that have provided some relief for some people:
- Dialysis: Dialysis helps remove gadolinium from your body after an MRI. This may be helpful for people with kidney disease. However, there is no guarantee that this will stop NSF from developing.
- Physical Therapy: Physical therapy can help maintain the mobility and flexibility of your joints.
- Kidney Transplants: This may be an option for some NSF patients.
The most important thing is to avoid exposure to gadolinium if you have kidney disease. But sometimes gadolinium may be necessary to get the best images from an MRI. In such cases, your doctor will weigh the benefits of the MRI against the very small risks of gadolinium .
When should I see the doctor?
With current safety measures, your chances of developing NSF are almost zero. However, if you have kidney disease and are scheduled to have an MRI, it's best to talk to your doctor about it.
Here are the times when you should see your doctor.
| Status | What to do |
|---|---|
If you have kidney disease and develop the following symptoms after receiving contrast dye for an MRI:
| See your doctor immediately. Describe your symptoms clearly. |
| If you have kidney disease and your doctor orders an MRI with contrast dye. | Talk to your doctor about the risk of NSF. Ask, "Is there a risk with this contrast because I have kidney problems?" Tell him or her your full health history. |
Although the newer GBCAs are non-toxic and appear to be safe, it is always a good idea to share your health history with your doctor and discuss any risks.
Take-Home Message
- Nephrogenic Systemic Fibrosis (NSF) is a now very rare disease that was caused when people with kidney disease were given old contrast dyes for MRI.
- This can cause thickening and hardening of the skin, and affect joints and internal organs.
- Because doctors are now more aware of this risk and use safer, newer contrast dyes, no new cases of NSF have been reported in more than 10 years.
- Since there is no specific treatment for this, prevention is the most important thing.
- If you have kidney disease and need to have an MRI with contrast dye, always talk to your doctor about the potential risks.
💬 අදහස් (0)
තවමත් කිසිදු අදහසක් පළ කර නොමැත. ඔබේ අදහස පළමු වරට මෙහි එක් කරන්න.
ඔබේ අදහස එක් කරන්න